In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus
Clinical trial NCT01453140 · TERMINATED
Trial details
- NCT number
- NCT01453140
- Sponsor
- Hackensack Meridian Health
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2012-03-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.